Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
King Pharmaceuticals, Inc.
Tennessee-based branded pharmaceutical company reports Q4, year end 2004 results
April 26th, 2005
King Pharmaceuticals, Inc. (KG) announced that total revenues decreased 6% to $342.6 million during the fourth quarter ending December 31, 2004, compared to $366 million in the fourth quarter of 2003. Including special items, net earnings equaled $14.7 million and diluted earnings per share equaled $0.06 during the fourth quarter of 2004, each decreasing 50% compared to net earnings of $29.3 million and diluted earnings per share of $0.12 in the same period of the prior year. Net earnings, excluding special items, equaled $33.8 million and diluted earnings per share equaled $0.14 during the fourth quarter ending December 31, 2004, each decreasing 50% compared to net...
Source: Cardiovascular Business Week (2005-04-26)
|
